Share
Print
Restricted Call to maximise impact of IMI2 JU objectives and scientific priorities
Details
Location:EU 27, Switzerland
Funding agency:
Grantmaking entity type:Development Institution
Description
Call Updates:
Dec 18, 2019 2:35:55 PM
An overview of the evaluation results (Flash Call Info - IMI2 Call 19-single-stage) is now available under the Call ‘Additional documents’ tab.
Sep 27, 2019 10:35:24 AM
Proposal numbers
The submission deadline for the Call IMI2-2019-19-single-stage closed on the 26 September 2019.
5 proposals have been submitted.
Evaluation results are expected to be communicated in December 2019.
Jun 26, 2019 12:30:00 AM
The submission session is now available for: IMI2-2019-19-01(IMI2-RIA)
Restricted Call to maximise impact of IMI2 JU objectives and scientific priorities
ID: IMI2-2019-19-01
Type of action: IMI2-RIA Research and Innovation action
Deadline Model : single-stage
Opening: 26 June 2019
Deadline: 26 September 2019 17:00:00 Brussels time
Horizon 2020
Call name: H2020-JTI-IMI2-2019-19-single-stage
Call ID: H2020-JTI-IMI2-2019-19-single-stage
Specific Challenge:A major challenge in life sciences, in particular within the medicines development process, is the scale of the investment required, the stepwise approach, very long development timelines and the successful involvement of relevant stakeholders. Certain IMI2 JU topics, launched under IMI2 JU Calls for proposals that are now closed, anticipated in their corresponding work plans the need for a stepwise approach.
Scope:The scope of the restricted Call will be to support further research activities in those exceptional cases where it is necessary to enable successful consortia to build on the achievements of their initial action, move onto the next step of the challenge, and maximise the impacts of the initial action results.
Expected Impact:enhancement of the impacts already delivered by the consortium in the initial action;
improvement drug development process;
public health benefits and improved European citizens’ health and well-being;
contribution to the EU’s industrial leadership including small and medium-sized enterprises (SMEs);
impact on regulatory, health technology assessment, and healthcare practices, if relevant;
further maximisation of the IMI2 JU public-private partnership value by harnessing support from different stakeholders, including the mobilisation of funds through the inclusion of contributing partners – not necessarily involved in the initial project – to reflect the public-private character of IMI2 JU actions.
Similar grants
By Locations
Funding agency:
Horizon 2020
Status:
awarded
Location:
EU 27, Switzerland
Funding agency:
Horizon 2020
Status:
awarded
Location:
EU 27, Switzerland
By Sectors
Funding agency:
EC
Status:
awarded
Location:
Kosovo
Funding agency:
Horizon 2020
Status:
awarded
Location:
EU 27, Switzerland
grant Background
About the Funding Agency
Horizon 2020 - is a Framework Programme for Research and Technological Development, and is created by the European Union in order to support and encourage research in the European Research Area (ERA). This is the biggest EU Research and Innovation programme ever with nearly €80 billion of funding available over 7 years (2014 to 2020). By coupling research and innovation, Horizon 2020 is helping to achieve this with its emphasis on excellent science, industrial leadership and tackling societal challenges. The goal is to ensure Europe produces world-class science, removes barriers to innovation and makes it easier for the public and private sectors to work together in delivering innovation. The Horizon 2020 programme running from 2014 to 2020 has a €79 billion budget (a 46% increase over FP7).
It is structured around three core pillars:
- Excellent Science (~€24.4bn)
- Industrial Leadership (~€17bn)
- Societal Challenges (~€29.7bn)
Type of projects: mostly grants, no supplies, no works.
In order to see Horizon 2020 opportunities on DevelopmentAid, please click here.
About the Sectors
Health
Covers healthcare services, public health systems, and activities aimed at promoting physical and mental well-being.
Key areas:
- Healthcare services and facilities
- Public health and disease prevention
- Medical equipment, supplies, and services
Research & Innovation
Focuses on collecting data, generating new knowledge, and applying it to develop improved methods, technologies, products, and solutions across sectors.
Key areas:
- Scientific research, studies, and investigations
- Innovation programs and applied R&D initiatives
- Technology development
- Space-related research and exploration themes
Locations
Switzerland
Switzerland maintains advanced rail networks, road systems, energy infrastructure, and digital connectivity to support its high-value industrial and financial economy. Significant investment focuses on rail tunnels, sustainable transport, and renewable energy integration. Infrastructure financing is supported by strong public finances and long-term strategic planning. Climate neutrality goals, alpine geography, and cross-border integration influence infrastructure development.
Nr. of tenders: 12060
Nr. of grants: 4000
Nr. of donors: 413
Nr. of jobs: 47
Nr. of tenders: 12060
Nr. of grants: 4000
Nr. of donors: 413
Nr. of jobs: 47
Frequently Asked Questions
Haven't found what you're looking for? Get in touch with us using our contact page.
Where can I find international grant opportunities?
DevelopmentAid collects grant opportunities from bilateral donors, multilateral agencies, foundations, and international organizations in one centralized platform.
Who can apply for grants listed on DevelopmentAid?
Grants are typically open to NGOs, civil society organizations, research institutions, public entities, and sometimes private organizations or consortia.
Does DevelopmentAid help with grant applications?
DevelopmentAid does not write or submit applications, but it provides access to full call details, guidelines, deadlines, and donor information needed to apply.